≡

Ribonuclease Inhibitor (RI)

[Edit]

RNH1; RNH; RAI; Ribonuclease/Angiogenin Inhibitor 1; Placental ribonuclease inhibitor; Placental RNase inhibitor

Ribonuclease Inhibitor (RI)
CCC B444
HGNC 10074
MGI 1195456
PubMed 12560499
RGD 621398
UniProt P13489
Wiki RI

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB444Hu01 Recombinant Ribonuclease Inhibitor (RI) Positive Control; Immunogen; SDS-PAGE; WB.
RPB444Hu02 Recombinant Ribonuclease Inhibitor (RI) Positive Control; Immunogen; SDS-PAGE; WB.
RPB444Hu03 Recombinant Ribonuclease Inhibitor (RI) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB444Hu01 Polyclonal Antibody to Ribonuclease Inhibitor (RI) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Ribonuclease Inhibitor (RI) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ribonuclease Inhibitor (RI) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB444Mu01 Recombinant Ribonuclease Inhibitor (RI) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB444Mu01 Polyclonal Antibody to Ribonuclease Inhibitor (RI) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Ribonuclease Inhibitor (RI) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ribonuclease Inhibitor (RI) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB444Ra01 Recombinant Ribonuclease Inhibitor (RI) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB444Ra01 Polyclonal Antibody to Ribonuclease Inhibitor (RI) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Ribonuclease Inhibitor (RI) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ribonuclease Inhibitor (RI) ELISA Kit Customized Service Offer
  1. "Primary structure of human placental ribonuclease inhibitor."Biochemistry 27:8545-8553(1988) [PubMed] [Europe PMC] [Abstract]
  2. "The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module."EMBO J. 7:4151-4156(1988) [PubMed] [Europe PMC] [Abstract]
  3. "Expression of a human ribonuclease inhibitor variant in Escherichia coli and silkworm insect cell (Bombyx mori)."Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35:960-963(2003) [PubMed] [Europe PMC] [Abstract]
  4. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Purification and characterization of human brain ribonuclease inhibitor."Arch. Biochem. Biophys. 312:421-428(1994) [PubMed] [Europe PMC] [Abstract]
  7. "Characterisation of a tryptic peptide from human placental ribonuclease inhibitor which inhibits ribonuclease activity."Biochim. Biophys. Acta 1122:107-112(1992) [PubMed] [Europe PMC] [Abstract]
  8. "Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A."Proc. Natl. Acad. Sci. U.S.A. 94:1761-1766(1997) [PubMed] [Europe PMC] [Abstract]
  9. "Superadditive and subadditive effects of 'hot spot' mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A."Biochemistry 38:9273-9285(1999) [PubMed] [Europe PMC] [Abstract]
  10. "Mutational analysis of the complex of human RNase inhibitor and human eosinophil-derived neurotoxin (RNase 2)."Biochemistry 42:1451-1459(2003) [PubMed] [Europe PMC] [Abstract]
  11. "The cytosolic ribonuclease inhibitor contributes to intracellular redox homeostasis."FEBS Lett. 581:930-934(2007) [PubMed] [Europe PMC] [Abstract]
  12. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  13. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  14. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  15. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  16. "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]
  17. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  18. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  19. "Molecular recognition of human angiogenin by placental ribonuclease inhibitor -- an X-ray crystallographic study at 2.0-A resolution."EMBO J. 16:5162-5177(1997) [PubMed] [Europe PMC] [Abstract]
  20. "Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor."J. Mol. Biol. 347:637-655(2005) [PubMed] [Europe PMC] [Abstract]
  21. "Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein."J. Mol. Biol. 368:434-449(2007) [PubMed] [Europe PMC] [Abstract]